Since HTRA1 was positively correlated with the poor prognosis of CRC patients with chemotherapy, we further conducted the drug sensitivity experiments, and confirmed the inhibition of HTRA1 on chemosenitivity. The gene discussed is HTRA1; the disease is colorectal carcinoma.